Octapharma to invest $1.5 billion in South Carolina biomanufacturing campus

The 50-acre Rock Hill project is expected to create 1,500 full-time jobs and establish Octapharma’s first U.S. production site for plasma-derived therapies and trauma-care products.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.